Voyager Acquisition Corp Class A Ordinary Shares (VACH)
Voyager Acquisition Corp Class A Ordinary Shares (VACH) is a special purpose acquisition company (SPAC) established to identify and acquire a target business in the technology, media, or telecommunications sectors. As a SPAC, it is formed to raise capital through an initial public offering (IPO) with the intention of merging with or acquiring an existing private company to facilitate its public market entry. VACH focuses on providing investors with a streamlined route to access emerging growth opportunities in its targeted industries.
Company News
VERAXA Biotech and Secarna Pharmaceuticals announced a strategic research collaboration to develop next-generation antibody oligonucleotide conjugates (AOCs) for treating autoimmune and chronic immune diseases, combining their unique technology platforms.